Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
161,976,581
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
161,310,235
-
Shares change
-
+6,910,331
-
Total reported value, excl. options
-
$1,764,640,729
-
Value change
-
+$57,814,939
-
Put/Call ratio
-
5.2%
-
Number of buys
-
90
-
Number of sells
-
54
-
Price
-
$10.94
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2019
As of 30 Jun 2019 IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) had 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 161,310,235 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., BROWN CAPITAL MANAGEMENT LLC, UBS ASSET MANAGEMENT AMERICAS INC, Sarissa Capital Management LP, JANUS HENDERSON GROUP PLC, STATE STREET CORP, and MFN Partners Management, LP.
This table shows 192 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.